Researchers Explore Breakthrough Approach To Combat Devastating Citrus Greening Disease
UF researchers are testing a new citrus tree that fights the insects causing citrus greening, offering hope for Florida's struggling citrus industry.
UF News
Genascence Announces Six-Month Results From Phase 1b DONATELLO Trial Indicating GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms
UF startup Genascence Corporation, a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, announced positive interim safety and biomarker results from the Phase 1b DONATELLO clinical trial evaluating GNSC-001.
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology
UF startup Cannabix Technologies Inc., developer of marijuana and alcohol breath testing devices, has announced that it has made significant updates to its Cannabix Marijuana Breathalyzer technology to meet suggested emerging regulatory requirements in preparation for marketing.
Herbicide Threatens Manatee Immune Systems, UF Study Finds
A University of Florida study focusing on manatees’ immune systems reveals how glyphosate, the world’s most commonly used herbicide, may threaten manatee health in an environment increasingly impacted by human activities.
Tech Tuesday: University of Florida Gator Robotics Team Design and Build BattleBots
In this week's Tech Tuesday, UF Innovate host Bethany Gaffey interviews Brooks Silber from the UF Gator Robotics team to learn about BattleBots.
Atsena Therapeutics Initiates Part B of Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics, a clinical-stage gene therapy company specializing in genetic medicine to reverse or prevent blindness, has announced the initiation of Part B of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating the subretinal injection of ATSN-201 for treating XLRS.
Solid Biosciences Announces FDA IND Clearance for First-in-Industry Dual Route of Administration Gene Therapy To Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia
Solid Biosciences Inc., a biotechnology company that acquired UF startup AavantiBio, announced that the U.S. FDA has cleared its Investigational New Drug application for SGT-212 for the treatment of Friedreich’s ataxia.
Dose Escalation Completed for Rise Therapeutics’ R-3750 and R-2487 Clinical Trials
UF startup Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, announced that it has completed dose escalation enrollment stages for both its R-2487 and R-3750 clinical trials.
The 21st Soil, Water, and Ecosystem Sciences Research Forum Highlights AI
UF researcher Alina Zare will be the keynote speaker at the 21st SWES Research Forum, highlighting how machine learning and AI can revolutionize problem-solving in agriculture and environmental science.
How To Avoid Winter Viruses: UF EPI Expert Talks RSV, Flu and COVID-19
UF researcher Frederick Southwick discusses the increased prevalence of respiratory viruses—influenza, COVID-19, and RSV—during the winter in Florida and provides tips on how to avoid them.
Want our news in your inbox every Monday morning? You can!